This proposal outlines studies designed to determine the role of endogenous non-cyclooxygenase metabolites of arachidonic acid in the modulation of the response of renal mesangial cells to growth factors and peptide vasoconstrictors. Inhibitors of the metabolism of arachidonate via cytochrome P450 monooxygenase and possibly lipoxygenase pathways potently suppress mitogenesis in mesangial cells. Mechanisms of this effect are unclear. One potential site of modulation is the calcium signal. The same inhibitors which suppress mitogenesis also markedly reduce the calcium transient following stimulation with peptide vasoconstrictors without affecting inositol polyphosphate release. Other data suggest an alteration in both the inositol trisphosphate-induced release of calcium from intracellular stores and an effect on cell membrane calcium channel function. It is postulated that non-cyclooxygenase eicosanoids modulate the intracellular expression of inositol polyphosphates, Ca++, and other messengers which couple mitogen-cell interactions to cell proliferation. The first specific aim will be to determine the mechanism of this modulation of the calcium transient. Effects on intracellular release as well as calcium channel function will be determined. The second specific aim will be to determine how these eicosanoids interact with signal transduction pathways other than the calcium messenger system. Specifically, these studies will determine whether they modulate protein kinase C activity, the tyrosine phosphorylation of growth factor receptors, or a novel protein tyrosine phosphorylation pattern recently identified here in mesangial cells in response to mitogenic vasoconstrictors. These studies should help clarify the function of non-cyclooxygenase metabolites of arachidonate in modulating growth.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08DK001986-03
Application #
3080902
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1990-09-20
Project End
1995-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Morooka, H; Bonventre, J V; Pombo, C M et al. (1995) Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter. J Biol Chem 270:30084-92
Pombo, C M; Bonventre, J V; Avruch, J et al. (1994) The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 269:26546-51
Force, T; Bonventre, J V; Heidecker, G et al. (1994) Enzymatic characteristics of the c-Raf-1 protein kinase. Proc Natl Acad Sci U S A 91:1270-4
Kyriakis, J M; Force, T L; Rapp, U R et al. (1993) Mitogen regulation of c-Raf-1 protein kinase activity toward mitogen-activated protein kinase-kinase. J Biol Chem 268:16009-19
Force, T; Bonventre, J V; Flannery, M R et al. (1992) A cloned porcine renal calcitonin receptor couples to adenylyl cyclase and phospholipase C. Am J Physiol 262:F1110-5
Force, T; Kyriakis, J M; Avruch, J et al. (1991) Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. J Biol Chem 266:6650-6